Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Jul. 31, 2020
Jul. 31, 2019
Current assets    
Cash and cash equivalents $ 20,354,462 $ 25,147,780
Prepaid expenses and other current assets 2,467,223 3,359,556
Total Current Assets 22,821,685 28,507,336
Property and equipment, net 814,494 1,031,129
Operating right-of-use assets 5,948,224
Other long-term assets 319,058 353,547
Total Assets 29,903,461 29,892,012
Current liabilities    
Accounts payable and accrued liabilities 7,923,036 4,217,017
Accrued compensation related 285,127 676,223
Operating lease liabilities 500,357
Notes payable 969,509 83,760
Total Current Liabilities 9,678,029 4,977,000
Operating lease liabilities, net of current portion 5,874,442
Notes payable, net of current portion 480,554
Other long-term liabilities 635,913
Total Liabilities 16,033,025 5,612,913
Commitments and Contingencies (Note 10)
Stockholders' Equity    
Common stock authorized - 100,000,000 and 16,000,000 common shares with a par value of $0.0001 as of July 31, 2020 and July 31, 2019, respectively, common stock issued and outstanding - 23,054,474 and 10,633,043 common shares as of July 31, 2020 and July 31, 2019, respectively 2,305 1,063
Additional paid-in capital 214,789,808 177,656,149
Warrants issued and outstanding - 3,114,288 and 3,631,953 warrants as of July 31, 2020 and July 31, 2019, respectively 5,708,127 10,809,724
Accumulated other comprehensive income (loss) (19,504) 169,037
Accumulated deficit (206,610,300) (164,356,874)
Total Stockholders' Equity 13,870,436 24,279,099
Total Liabilities and Stockholders' Equity $ 29,903,461 $ 29,892,012